In a murine model of hypertension, a highly selective SGK1 inhibitor, EMD638683, was shown to suppress IL-1β release, NLRP3 expression, and caspase-1 activation which was associated by reduced transformation of fibroblasts to myofibroblasts (130). Here, NLRP3 is linked to hypertensive disorder.